-
Signature
-
/s/ Todd Rosenthal, as attorney-in-fact
-
Stock symbol
-
SYRS
-
Transactions as of
-
Sep 16, 2022
-
Transactions value $
-
$0
-
Form type
-
4/A - Amendment
-
Date filed
-
4/20/2023, 04:39 PM
-
Date Of Original Report
-
Sep 19, 2022
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
SYRS |
Common Stock |
Award |
|
+691K |
+364.02% |
|
881K |
Sep 16, 2022 |
See footnote |
F1, F2, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
SYRS |
Stock Option (right to buy) |
Award |
$0 |
+12K |
|
$0.00 |
12K |
Sep 16, 2022 |
Common Stock |
12K |
$7.35 |
Direct |
F4 |
transaction |
SYRS |
Restricted Stock Units |
Award |
$0 |
+8K |
|
$0.00 |
8K |
Sep 16, 2022 |
Common Stock |
8K |
|
Direct |
F5, F6 |
transaction |
SYRS |
Warrants (right to buy) |
Award |
|
+691K |
|
|
691K |
Sep 16, 2022 |
Common Stock |
691K |
$10.34 |
See footnote |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
This amendment to the Statement of Changes in Beneficial Ownership of Securities is being filed to correct the inadvertent omission of the Reporting Person's indirect beneficial ownership of certain securities held by Samsara Biocapital.